New drug shows promise in lung cancer fight
NCT ID NCT07019675
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called SKB518 in 192 adults with lung cancer (non-small cell or small cell). The goal is to see if it shrinks tumors and to check for side effects. Participants receive the drug alone until their disease gets worse or side effects become too severe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Cancer Hospital of Xinjiang Medical University
RECRUITINGÜrümqi, Xinjiang, China
-
Cancer Hospital Chinese Academy of Medical Science
RECRUITINGBeijing, China
-
Cancer Hospital of Guangxi Medical University
RECRUITINGNanning, Guangxi, China
-
Cancer Hospital of Shandong First Medical University
RECRUITINGJinan, Shandong, China
-
Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center
RECRUITINGShenzhen, Guangdong, China
-
Hubei Cancer Hospital
RECRUITINGWuhan, Hubei, China
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, China
-
Jiangxi Cancer Hospital
RECRUITINGNanchang, Jiangxi, China
-
Renmin Hospital of Wuhan University
RECRUITINGWuhan, Hubei, China
-
Shanghai Pulmonary Hospital (Affiliated to Tongji University)
RECRUITINGShanghai, China
-
Shanxi Cancer Hospital
RECRUITINGTaiyuan, Shanxi, China
-
Taizhou Hospital of Zhejiang Province
RECRUITINGTaizhou, Zhejiang, China
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, China
-
Tianjin Medical University Cancer Institute & Hospital
RECRUITINGTianjin, China
-
Xiangyang Central Hospital
RECRUITINGXiangyang, Hubei, China
-
Yunnan Cancer Hospital
RECRUITINGKunming, Yunnan, China
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?